Leaving behind pegylated interferon-based regimens to eliminate hepatitis C as a public health threat by 2030 as set out by WHO

Liver Int. 2018 Nov;38(11):1902-1905. doi: 10.1111/liv.13944.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antiviral Agents*
  • Hepatitis C, Chronic*
  • Hong Kong
  • Humans
  • Interferons
  • Public Health

Substances

  • Antiviral Agents
  • Interferons